Sensory and Psychomotor Profile in Depression (DEPCOR)

July 19, 2021 updated by: Aude Paquet, Centre Hospitalier Esquirol

Despite a possible psychomotor retardation during a depressive episode, standardized psychomotor assessment is rare. So, other possible psychomotor disorders or neurological "soft signs" are not known in depression.

The investigator propose in this study to explore the psychomotor characteristics of patients with a major depressive disorder from the realization of a psychomotor assessment in comparison with adult without depressive disorder (control). It will be specifically assess muscle tone, gross motor skills, praxis, body schema and the body image and the perceptions.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Limoges, France, 87000
        • Centre Hospitalier Esquirol

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • major depressive disorder according to the DSM-5
  • aged to 18 from 65 years old

Exclusion Criteria:

  • psychiatric comorbidity (bipolar, addiction, eating disorder, personality disorder, obsessional compulsive disorder)
  • antipsychotic drug
  • taken care in psychomotor therapy previously
  • electroconvulsive therapy
  • medical history of neurologic disease, neurodevelopmental disorder, sensory disability
  • Constraint Hospitalization
  • under legal protection
  • pregnant
  • lack of consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SCREENING
  • Allocation: NON_RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: major depressive disorder
psychometric scales psychomotor assessment
the intervention include a depression scale, an anxiety scale, a sensory profile scale, a body image questionnaire, a self-esteem questionnaire, a psychomotor retardation scale and a standardized assessment of : muscle tone (dangling and extensibility); gross motor skills (walks, jump, static balance, dynamic balance); manual performance; manual praxis; adaptation of rhythm; manual gnosis; executive function
ACTIVE_COMPARATOR: Control
psychometric scales psychomotor assessment
the intervention include a depression scale, an anxiety scale, a sensory profile scale, a body image questionnaire, a self-esteem questionnaire, a psychomotor retardation scale and a standardized assessment of : muscle tone (dangling and extensibility); gross motor skills (walks, jump, static balance, dynamic balance); manual performance; manual praxis; adaptation of rhythm; manual gnosis; executive function

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
% of patients with a distinctive feature at the sensory profile questionnaire from the AASP
Time Frame: At inclusion
Scores at the AASP psychomotor battery are considered. A failure is considered from a result <1SD compared to the control group.
At inclusion
% of patients with a failure at the muscle tone test from the NP-MOT battery
Time Frame: At inclusion
Scores at the NP-MOT psychomotor battery are considered. A failure is considered from a result <1SD compared to the control group.
At inclusion
% of patients with a failure at the gross motor test from the NP-MOT battery
Time Frame: At inclusion
Scores at the NP-MOT psychomotor battery are considered. A failure is considered from a result <1SD compared to the control group.
At inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 23, 2018

Primary Completion (ACTUAL)

March 23, 2019

Study Completion (ACTUAL)

October 15, 2019

Study Registration Dates

First Submitted

June 13, 2019

First Submitted That Met QC Criteria

July 22, 2019

First Posted (ACTUAL)

July 24, 2019

Study Record Updates

Last Update Posted (ACTUAL)

July 20, 2021

Last Update Submitted That Met QC Criteria

July 19, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Major Depressive Disorder

Clinical Trials on Psychomotor assessment

Subscribe